MENU
+Compare
ITRM
Stock ticker: NASDAQ
AS OF
Dec 26, 04:59 PM (EDT)
Price
$0.31
Change
-$0.00 (-0.00%)
Capitalization
16.58M

ITRM Iterum Therapeutics plc Forecast, Technical & Fundamental Analysis

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology
ITRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ITRM with price predictions
Dec 24, 2025

ITRM's Stochastic Oscillator is remaining in oversold zone for 6 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ITRM advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

ITRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ITRM as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ITRM turned negative on December 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ITRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ITRM entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (29.499) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ITRM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ITRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ITRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ITRM is expected to report earnings to fall 43.75% to -9 cents per share on March 12

Iterum Therapeutics plc ITRM Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Missed
by $0.05
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.10
The last earnings report on November 14 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 548.28K shares outstanding, the current market capitalization sits at 16.58M.
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRZN22.90-0.07
-0.28%
Surrozen
GFI46.01-0.16
-0.35%
Gold Fields Ltd
AUGO51.77-0.19
-0.37%
Aura Minerals Inc
ODV3.65-0.02
-0.54%
Osisko Development Corp
CANF0.18-0.06
-25.03%
Can-Fite BioPharma Ltd

ITRM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with ENSC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-7.89%
ENSC - ITRM
37%
Loosely correlated
-0.89%
AURA - ITRM
35%
Loosely correlated
-2.65%
RGNX - ITRM
34%
Loosely correlated
+0.77%
CHRS - ITRM
34%
Loosely correlated
+1.52%
NVAX - ITRM
34%
Loosely correlated
+2.06%
More